• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于使用抗逆转录病毒疗法治疗HIV感染的实际问题。

Practical issues regarding the use of antiretroviral therapy for HIV infection.

作者信息

Deeks S G

机构信息

University of California, School of Medicine, San Francisco 94110, USA.

出版信息

West J Med. 1998 Feb;168(2):133-9.

PMID:9499754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1304849/
Abstract

With the recent development of potent new antiretroviral therapies, the management of HIV infection has become increasingly complex. There are now 12 antiretroviral drugs approved for use in the management of HIV infection, with several more in the advanced stages of clinical development. Staying current with this rapidly changing area of medicine is a challenge to clinicians caring for HIV-infected patients. This review provides an overview of HIV pathogenesis and discusses the basic principles of therapy. These principles, developed recently by the U.S. Department of Health and Human Services, provide a practical framework to rapidly incorporate new developments into clinical practice. Each of the three classes of antiretroviral therapies is then explained, focusing on the practical management of side effects, drug interactions, and viral resistance. The antiviral activity and clinical efficacy of each therapeutic class is reviewed, with an emphasis on applying current results to clinical decision making. Finally, recently published treatment guidelines are reviewed.

摘要

随着强效新型抗逆转录病毒疗法的近期发展,HIV感染的管理变得日益复杂。目前有12种抗逆转录病毒药物被批准用于HIV感染的管理,还有几种正处于临床开发的后期阶段。对于照顾HIV感染患者的临床医生而言,紧跟这一快速变化的医学领域是一项挑战。本综述概述了HIV发病机制,并讨论了治疗的基本原则。这些原则由美国卫生与公众服务部近期制定,提供了一个将新进展迅速纳入临床实践的实用框架。然后对三类抗逆转录病毒疗法中的每一类进行了解释,重点关注副作用、药物相互作用和病毒耐药性的实际管理。对每类治疗方法的抗病毒活性和临床疗效进行了综述,重点是将当前结果应用于临床决策。最后,对最近发布的治疗指南进行了综述。

相似文献

1
Practical issues regarding the use of antiretroviral therapy for HIV infection.关于使用抗逆转录病毒疗法治疗HIV感染的实际问题。
West J Med. 1998 Feb;168(2):133-9.
2
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
3
Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.抗逆转录病毒治疗。成人HIV感染:定义更明确的一线治疗。
Prescrire Int. 2004 Aug;13(72):144-50.
4
Salvage therapy: still more intuition than data.
GMHC Treat Issues. 1999 Jan;13(1):6-12.
5
Antiretroviral therapies.抗逆转录病毒疗法
Clin Podiatr Med Surg. 1998 Apr;15(2):227-39.
6
Antiretroviral update: recent advances expand options for patients with HIV.抗逆转录病毒治疗进展:近期进展为艾滋病患者拓展了治疗选择。
Adv Nurse Pract. 2004 Nov;12(11):53-4, 56.
7
New antiretrovirals and new combinations.
AIDS. 1998;12 Suppl A:S165-74.
8
Antiretroviral therapy in human immunodeficiency virus-infected individuals.人类免疫缺陷病毒感染者的抗逆转录病毒疗法。
Adv Intern Med. 1998;43:373-402.
9
Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.逆转录酶抑制剂和蛋白酶抑制剂的原理及应用经验。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S58-61.
10
State of the art: antiretroviral and prophylactic treatments in HIV/AIDS.最新技术水平:HIV/AIDS的抗逆转录病毒治疗和预防性治疗
Nurs Clin North Am. 1999 Mar;34(1):95-112.

引用本文的文献

1
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.一项关于维生素 C 的使用与高效抗逆转录病毒治疗(HAART)依从性和有效性之间可能存在相互作用的调查,该研究对象为接受治疗的 HIV+女性。
Complement Ther Med. 2012 Aug;20(4):222-7. doi: 10.1016/j.ctim.2012.03.001. Epub 2012 Apr 8.
2
Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.补充和替代医学的使用与高效抗逆转录病毒治疗开始之间的关联。
Altern Ther Health Med. 2008 Sep-Oct;14(5):18-22.

本文引用的文献

1
Crystalluria and urinary tract abnormalities associated with indinavir.
Ann Intern Med. 1997 Jul 15;127(2):119-25. doi: 10.7326/0003-4819-127-2-199707150-00004.
2
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.1997年人类免疫缺陷病毒感染的抗逆转录病毒疗法。美国国际艾滋病学会小组的最新建议。
JAMA. 1997 Jun 25;277(24):1962-9.
3
Genotypic-resistance assays and antiretroviral therapy.
Lancet. 1997 May 24;349(9064):1489-90. doi: 10.1016/S0140-6736(05)62092-2.
4
British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee.英国HIV协会关于HIV血清阳性个体抗逆转录病毒治疗的指南。英国HIV协会指南协调委员会。
Lancet. 1997 Apr 12;349(9058):1086-92.
5
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.司他夫定单药治疗与齐多夫定治疗在有齐多夫定治疗史的HIV感染患者中的临床疗效比较。一项随机、双盲、对照试验。百时美施贵宝司他夫定/019研究组。
Ann Intern Med. 1997 Mar 1;126(5):355-63. doi: 10.7326/0003-4819-126-5-199703010-00003.
6
HIV-1 protease inhibitors. A review for clinicians.人类免疫缺陷病毒1型蛋白酶抑制剂。临床医生综述
JAMA. 1997 Jan 8;277(2):145-53.
7
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.体内对人免疫缺陷病毒1型蛋白酶抑制剂茚地那韦的病毒抗性的遗传关联
J Virol. 1996 Dec;70(12):8270-6. doi: 10.1128/JVI.70.12.8270-8276.1996.
8
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.一项针对每立方毫米CD4细胞计数为200至500的HIV感染成人,比较核苷单药疗法与联合疗法的试验。艾滋病临床试验组研究175研究团队。
N Engl J Med. 1996 Oct 10;335(15):1081-90. doi: 10.1056/NEJM199610103351501.
9
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.奈韦拉平、齐多夫定和去羟肌苷与齐多夫定和去羟肌苷治疗HIV-1感染患者的比较。一项随机、双盲、安慰剂对照试验。美国国立过敏与传染病研究所艾滋病临床试验组方案241研究者。
Ann Intern Med. 1996 Jun 15;124(12):1019-30. doi: 10.7326/0003-4819-124-12-199606150-00001.
10
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.体内HIV-1动态变化:病毒体清除率、受感染细胞寿命及病毒生成时间。
Science. 1996 Mar 15;271(5255):1582-6. doi: 10.1126/science.271.5255.1582.